Logo image of GPX

Gp Strategies Corp (GPX) Stock Fundamental Analysis

NYSE:GPX - New York Stock Exchange, Inc. -

20.85  0 (0%)

After market: 20.85 0 (0%)

Fundamental Rating

2

GPX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. GPX has a bad profitability rating. Also its financial health evaluation is rather negative. GPX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GPX was profitable.

1.2 Ratios

Industry RankSector Rank
ROA 3.53%
ROE 5.71%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 4.22%
PM (TTM) 2.73%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

GPX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

GPX has an Altman-Z score of 3.85. This indicates that GPX is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.04 indicates that GPX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 3.85
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.97 indicates that GPX should not have too much problems paying its short term obligations.
A Quick Ratio of 1.97 indicates that GPX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.97

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 540.00% over the past year.
The earnings per share for GPX have been decreasing by -27.28% on average. This is quite bad
Looking at the last year, GPX shows a decrease in Revenue. The Revenue has decreased by -8.85% in the last year.
The Revenue has been decreasing by -0.71% on average over the past years.
EPS 1Y (TTM)540%
EPS 3Y-41.68%
EPS 5Y-27.28%
EPS Q2Q%925%
Revenue 1Y (TTM)-8.85%
Revenue growth 3Y-2.42%
Revenue growth 5Y-0.71%
Sales Q2Q%21.33%

3.2 Future

GPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 87.33% yearly.
Based on estimates for the next years, GPX will show a small growth in Revenue. The Revenue will grow by 6.00% on average per year.
EPS Next Y339.07%
EPS Next 2Y125.03%
EPS Next 3Y98.81%
EPS Next 5Y87.33%
Revenue Next Year5.74%
Revenue Next 2Y6.26%
Revenue Next 3Y5.91%
Revenue Next 5Y6%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GPX Yearly Revenue VS EstimatesGPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
GPX Yearly EPS VS EstimatesGPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

GPX is valuated rather expensively with a Price/Earnings ratio of 21.72.
The average S&P500 Price/Earnings ratio is at 25.25. GPX is around the same levels.
GPX is valuated rather expensively with a Price/Forward Earnings ratio of 17.16.
GPX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.27.
Industry RankSector Rank
PE 21.72
Fwd PE 17.16
GPX Price Earnings VS Forward Price EarningsGPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.35
GPX Per share dataGPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

GPX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GPX's earnings are expected to grow with 98.81% in the coming years.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y125.03%
EPS Next 3Y98.81%

0

5. Dividend

5.1 Amount

No dividends for GPX!.
Industry RankSector Rank
Dividend Yield N/A

Gp Strategies Corp

NYSE:GPX (10/14/2021, 8:50:17 PM)

After market: 20.85 0 (0%)

20.85

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-04 2021-11-04
Earnings (Next)03-10 2022-03-10/bmo
Inst Owners3.54%
Inst Owner Change0%
Ins Owners1.83%
Ins Owner Change0%
Market Cap365.94M
Analysts60
Price Target21.27 (2.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 21.72
Fwd PE 17.16
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 1.59
P/tB N/A
EV/EBITDA 13.35
EPS(TTM)0.96
EY4.6%
EPS(NY)1.22
Fwd EY5.83%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS27.46
BVpS13.15
TBVpSN/A
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.53%
ROE 5.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.22%
PM (TTM) 2.73%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.97
Altman-Z 3.85
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)540%
EPS 3Y-41.68%
EPS 5Y-27.28%
EPS Q2Q%925%
EPS Next Y339.07%
EPS Next 2Y125.03%
EPS Next 3Y98.81%
EPS Next 5Y87.33%
Revenue 1Y (TTM)-8.85%
Revenue growth 3Y-2.42%
Revenue growth 5Y-0.71%
Sales Q2Q%21.33%
Revenue Next Year5.74%
Revenue Next 2Y6.26%
Revenue Next 3Y5.91%
Revenue Next 5Y6%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A